Literature DB >> 15156473

Laboratory-confirmed shigellosis in the United States, 1989-2002: epidemiologic trends and patterns.

Amita Gupta1, Christina S Polyak, Richard D Bishop, Jeremy Sobel, Eric D Mintz.   

Abstract

During 1989-2002, a total of 208,368 laboratory-confirmed Shigella infections were reported to the Centers for Disease Control and Prevention. Shigella sonnei accounted for 71.7%, Shigella flexneri accounted for 18.4%, Shigella boydii accounted for 1.6%, and Shigella dysenteriae accounted for 0.7% of infections; for 7.6%, no serogroup was reported. National incidence rates ranged from 7.6 cases per 100,000 persons in 1993 to 3.7 cases per 100,000 persons in 1999. Incidence rates for S. boydii, S. dysenteriae, and S. flexneri decreased over the 14-year period by 81%, 83%, and 64%, respectively; S. sonnei rates only decreased by 8%. The highest rates were reported from western states (10.0 cases per 100,000 persons) and among children 1-4 years of age (20.6 cases per 100,000 persons). The female-male S. sonnei incidence rate ratio among 20-39-year-old adults decreased from 2.3 during 1989-1999 to 1.4 during 2000-2002. Approximately 1% of isolates were from extraenteric sources; 0.25% were from blood. S. sonnei remains an important cause of diarrhea in the United States. Prevention efforts that target high-risk groups are needed.

Entities:  

Mesh:

Year:  2004        PMID: 15156473     DOI: 10.1086/386326

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  39 in total

1.  A recurring outbreak of Shigella sonnei among traditionally observant Jewish children in New York City: the risks of daycare and household transmission.

Authors:  V Garrett; K Bornschlegel; D Lange; V Reddy; L Kornstein; J Kornblum; A Agasan; M Hoekstra; M Layton; J Sobel
Journal:  Epidemiol Infect       Date:  2006-04-20       Impact factor: 2.451

2.  Multilocus variable-number tandem-repeat analysis for molecular typing of Shigella sonnei.

Authors:  Shiu-Yun Liang; Haruo Watanabe; Jun Terajima; Chun-Chin Li; Jui-Cheng Liao; Sheng Kai Tung; Chien-Shun Chiou
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

3.  Use of a prospective space-time scan statistic to prioritize shigellosis case investigations in an urban jurisdiction.

Authors:  Roderick C Jones; Monica Liberatore; Julio R Fernandez; Susan I Gerber
Journal:  Public Health Rep       Date:  2006 Mar-Apr       Impact factor: 2.792

4.  Distribution of genes encoding virulence factors of Shigella strains isolated from children with diarrhea in southwest Iran.

Authors:  Nabi Jomehzadeh; Khadijah Ahmadi; Hazhir Javaherizadeh; Maryam Afzali
Journal:  Mol Biol Rep       Date:  2021-02-06       Impact factor: 2.316

5.  Foodborne outbreaks of shigellosis in the USA, 1998-2008.

Authors:  B L Nygren; K A Schilling; E M Blanton; B J Silk; D J Cole; E D Mintz
Journal:  Epidemiol Infect       Date:  2012-02-24       Impact factor: 2.451

6.  An update on vaccines against Shigella.

Authors:  Shai Ashkenazi; Dani Cohen
Journal:  Ther Adv Vaccines       Date:  2013-09

Review 7.  Shigella flexneri: an emerging pathogen.

Authors:  Iqbal Nisa; Muhammad Qasim; Nusrat Yasin; Rafi Ullah; Anwar Ali
Journal:  Folia Microbiol (Praha)       Date:  2020-02-05       Impact factor: 2.099

8.  A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation.

Authors:  Ha Vinh; Nguyen Thi Khanh Nhu; Tran Vu Thieu Nga; Pham Thanh Duy; James I Campbell; Nguyen Van Minh Hoang; Maciej F Boni; Phan Vu Tra My; Christopher Parry; Tran Thi Thu Nga; Pham Van Minh; Cao Thu Thuy; To Song Diep; Le Thi Phuong; Mai Thu Chinh; Ha Thi Loan; Nguyen Thi Hong Tham; Mai Ngoc Lanh; Bui Li Mong; Vo Thi Cuc Anh; Phan Van Be Bay; Nguyen Van Vinh Chau; Jeremy Farrar; Stephen Baker
Journal:  BMC Infect Dis       Date:  2009-12-15       Impact factor: 3.090

9.  Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity.

Authors:  S Barnoy; K I Jeong; R F Helm; A E Suvarnapunya; R T Ranallo; S Tzipori; M M Venkatesan
Journal:  Vaccine       Date:  2009-11-20       Impact factor: 3.641

10.  A unified approach to molecular epidemiology investigations: tools and patterns in California as a case study for endemic shigellosis.

Authors:  Sawsan Al-Nimri; Woutrina A Miller; Barbara A Byrne; Gerry Guibert; Lily Chen
Journal:  BMC Infect Dis       Date:  2009-11-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.